Industry News
Anivive Secures $20 Million Investment from Leonid Capital Partners to Develop the Next Generation of Pet Health
Funding expands manufacturing readiness for Valley fever vaccine This follows Anivive’s $33MM NIAID contract for fungal vaccines In total, Anivive has secured over $80MM in contracts and preorders Anivive Lifesciences,
February 28, 2025